On Friday, Charles Schwab Corp (NYSE:SCHW)’s shares declined -2.22% to $29.11.
At a time when independent registered investment advisor (RIA) firms’ revenue and profitability are reaching new highs1, the industry is seeing an uptick in merger and acquisition (M&A) activity, based on the number of deals in addition to the average deal size. According to the latest data compiled by Schwab Advisor Services, total and average deal size rose during the first six months of 2015 indicating that the industry has both the financial means and the appetite to make planned moves in order to achieve scale and gain competitive strength.
The first half of 2015 closed with 37 accomplished transactions, up from 29 over the same period in 2014, according to the data. Total transaction value raised 53 percent to $49.8 billion in assets under administration (AUM), a jump from $32.6 billion in the first half of 2014. Meanwhile, average deal size reached $1.3 billion in AUM, marking the highest average deal value since 2009, when the average transaction size for the entire year was $1.7 billion in AUM.
The Charles Schwab Corporation, through its auxiliaries, provides wealth administration, securities brokerage, banking, money administration, and financial advisory services. The company operates through two segments, Investor Services and Advisor Services.
E I Du Pont De Nemours And Co (NYSE:DD)’s shares dropped -3.88% to $48.59.
via PRWEB - The U.S. Environmental Protection Agency (EPA) has granted registration approval for a new DuPont disease control active ingredient, oxathiapiprolin, which DuPont Crop Protection will market under the trademark Zorvec(TM). This regulatory milestone paves the way for registrations in other countries that will enable DuPont to bring this innovative new technology to growers around the world.
DuPont(TM) Zorvec(TM) is the first member of a new class of fungicides which represents a step change improvement in disease control for growers of potatoes, grapes, vegetables and other specialty crops.
E.I. du Pont de Nemours and Company operates as a science and technology based company worldwide. The company’s Agriculture segment offers corn hybrid, soybean, canola, sunflower, sorghum, inoculants, seed products, wheat, rice, herbicides, fungicides, and insecticides. Its Electronics & Communications segment provides various materials and systems, counting photopolymers and electronic materials for photovoltaic products, consumer electronics, displays, and advanced printing.
At the end of Friday’s trade, Ambarella Inc (NASDAQ:AMBA)‘s shares surged 0.12% to $73.24.
Ambarella, Inc. (AMBA), a leading developer of low-power, HD video compression and image processing semiconductors, recently declared that Dr. Fermi Wang, CEO, and George Laplante, CFO, will present at the Deutsche Bank Technology Conference on Wednesday, Sept. 16th at The Cosmopolitan hotel in Las Vegas.
The presentation is planned for 3:20 p.m. Pacific time and will be webcast on the Investor information page of Ambarella’s website at http://investor.ambarella.com/index.cfm.
Ambarella, Inc. develops semiconductor processing solutions for video that enable high-definition (HD) video capture, sharing, and display worldwide. The company’s system-on-a-chip designs integrated HD video processing, image processing, audio processing, and system functions onto a single chip for delivering video and image quality, differentiated functionality, and low power consumption. I
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
